G-CSF (filgrastim) stimulation in the bone promotes, in concert with M-CSF and RANKL, the expansion and differentiation of macrophages (Ms) to osteoclasts (OCs), increasing osteoclast activity and leading to decreased bone mineral density and increased tumor cell production.